Provider Needs Assessment Survey
The WV IMPACT project is working with communities to create opportunities and address the needs of children diagnosed with Neonatal Abstinence Syndrome (NAS) or exposed to substances in utero. This […]
Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay
Today, Miriam Delphin-Rittmon, Ph.D., Assistant Secretary for Mental Health and Substance Use and the leader of the Substance Abuse and Mental Health Services Administration (SAMHSA), released the following statement in […]
